IOL CHEM AND PHARMA LTD
IOLCP · General/Diversified · NSE
₹93
Current Market Price
Fair Value (DCF)
₹48
Margin of Safety
-48.3%
Updated 18h ago
YieldIQ Score
15/100
Piotroski F-Score
3/9
Economic Moat
None
Confidence
42%
ROE
—
Debt/Equity
0.09
WACC
11.1%
Market Cap
₹2,717 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
8.3%
Return on capital employed
EV / EBITDA
11.4×
Enterprise multiple
Debt / EBITDA
0.5×
Leverage vs earnings
Interest Coverage
14.9×
EBIT covers interest
Current Ratio
1.89×
Short-term liquidity
Asset Turnover
0.87×
Revenue per ₹ of assets
Revenue CAGR (3Y)
-1.6%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹92.58
Bear case
₹32.32
MoS -186.4%
Base case
₹47.89
MoS -93.3%
Bull case
₹67.53
MoS -37.1%
Ratio Trends
IOLCP · last 8 annual periods
ROE
6.0%
ROCE
12.2%
Operating Margin
—
Debt / Equity
0.07×
PE
128.2×
EV / EBITDA
34.1×
Historical Financials
IOLCP · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹1967 Cr | ₹2184 Cr | ₹2202 Cr | ₹2119 Cr | ₹2068 Cr | +1.3% |
| EBITDA | — | ₹271 Cr | ₹246 Cr | ₹255 Cr | ₹220 Cr | -5.1% |
| EBIT | ₹577 Cr | ₹233 Cr | ₹91.9 Cr | ₹40.6 Cr | — | -48.5% |
| PAT | ₹445 Cr | ₹168 Cr | ₹139 Cr | ₹134 Cr | ₹101 Cr | -30.9% |
| EPS (diluted) | ₹76.21 | ₹28.56 | ₹11.03 | ₹4.71 | — | -50.1% |
| CFO | ₹380 Cr | ₹93.0 Cr | ₹122 Cr | ₹290 Cr | ₹179 Cr | -17.2% |
| CapEx | — | — | — | — | ₹-214 Cr | — |
| FCF | — | — | — | — | ₹-34.9 Cr | — |
| Total Assets | — | ₹1962 Cr | ₹2022 Cr | ₹2244 Cr | ₹2382 Cr | +5.0% |
| Total Debt | — | — | ₹79.6 Cr | ₹32.8 Cr | ₹117 Cr | +10.1% |
| Shareholders' Equity | — | — | ₹1508 Cr | ₹1612 Cr | ₹1688 Cr | +2.9% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
IOLCP vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| BLISSGVS BLISS GVS PHARMA LTD | -46.4% | 22 | Above Fair Value | 7.7% | — |
| ORCHPHARMA ORCHID PHARMA LIMITED | -28.8% | 29 | Above Fair Value | 7.9% | — |
| UNICHEMLAB UNICHEMLAB | — | — | Pending | 5.6% | — |
| SOLARA SOLARA | — | — | Pending | 0.0% | — |
| GUFICBIO GUFICBIO | — | — | Pending | 11.6% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for IOLCP in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. IOL CHEM AND PHARMA LTD (IOLCP.NS) trades at 92.58 vs a model fair value of 47.89, a gap of -48.3%. Piotroski F-score: 3/9. Moat label: N...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of IOLCP →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for IOLCP →
Compare
Head-to-head with peers
Compare IOLCP side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse IOLCPNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.